NGM
Ngm Biopharmaceuticals Inc
Halal Rating :
Last Price
$1.55
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for major diseases with unmet medical needs. The company's primary focus is on developing treatments for liver and metabolic diseases, oncology, and ophthalmic diseases.
The company generates revenue primarily through research and development collaboration agreements and license fees. They are still in the development phase with most of their products in clinical trials.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $165000.0 | $29.83m | - | - | 0.00% | 0.00% |
| Sept. 30, 2023 | $582000.0 | $31.61m | - | - | 0.00% | 0.00% |
| June 30, 2023 | $1.42m | $42.0m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Ngm Biopharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.